脑心通联合脉络宁治疗脑梗塞的临床治疗效果及其预后观察

目的观察脑心通液联合脉络宁治疗急性脑梗死的临床疗效。方法收集2017年1月~2018年12月在我院治疗的急性脑梗死患者60例,按照随机数表法分为两组,每组各30例,对照组单用脉络宁治疗,观察组采用脑心通联合脉络宁治疗,比较两组治疗前后NIHSS、ADL评分情况、临床疗效及预后不良反应发生情况。结果观察组总有效率为90.0%,对照组总有效率为53.3%,两组比较差异有统计学意义(<0.05)。两组治疗后14d神经功能缺损评分均较治疗前明显降低(<0.01),但观察组优于对照组(<0.05)。两组的不良反应发生率没有明显差别(>0.05)。结论脑心通液联合脉络宁治疗急性脑梗死安全有效,能改善患者的预后。

Curative Effect of Naoxintong Capsule in Treating Senile Cerebral Arteriosclerosis

Objective： To observe the curative effect of Naoxintong capsule in treating senile cerebral arteriosclerosis. Methods：60 cases of senile cerebral arteriosclerosis were randomly divided into the contrast group and the treatment group with 30 cases each group. Same medicine was used in two groups. The treatment group was added with Naoxintong capsule. The cerebrovascular hemodynamics index （CVDI） of fight carotid was compared before and after therapy. Results： CVDI of the treatment group after therapy was significantly different from that before therapy （ P 〈 0.05 ～ 0.01 ）. Conclusion： Naoxintong capsule has certain curative effect in treating senile cerebral arteriosclerosis.